Back to Careers

The Ending Age-Related Diseases Conference Featured Juvena CEO and CO-Founder, Hanadie Yousef, PhD, as a leading aging biology expert discussing “Building a Pipeline of Therapeutics that Target Diseases of Aging” and Dr. Thach Mai, leading Discovery Scientist, discussing Juvena’s innovative ML-enhanced platform for protein drug discovery Aug. 2022

Back to Careers

EARD 2022: Mapping Secreted Proteins to Unmet Medical Needs by Dr. Thach Mai at Juvena August 2022

Back to Careers

CSO and Co-Founder Dr. Jeremy O’Connell presents at FASEB Industry Panel Jul. 2022

Back to Careers

CEO Hanadie Yousef was honored to represent Juvena Therapeutics at BIO International Convention in June 2022, where she gave a Company Presentation at the emerging company showcase. She had numerous meetings with exciting companies and investors focused on partnerships and was all around inspired by the exceptional attendees, sponsors, and organizers. Thanks to The National Institutes of Health for sponsoring the Innovation Zone and Juvena’s attendance

Back to Careers

Juvena Therapeutics Awarded Highly Competitive 3.9M CIRM TRAN1 Grant to Advance Lead Program, JUV-161, to Treat Myotonic Dystrophy Type 1

Back to Careers

Hanadie served on a CEO panel with a group of portfolio companies for Bascom Ventures (part of Alumni Ventures)

Back to Careers

CIRM Awards Juvena a $3.9M TRAN1 Grant to Advance JUV-161 for Myotonic Dystrophy Type 1 (DM1)

Back to Careers

CEO Dr. Yousef Represents Juvena at Longevity Summit 2021

Back to Careers

CEO Dr. Hanadie Yousef Interviewed for Translating Aging Podcast, “The Cures Within Us”